JP2013531801A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013531801A5 JP2013531801A5 JP2013518768A JP2013518768A JP2013531801A5 JP 2013531801 A5 JP2013531801 A5 JP 2013531801A5 JP 2013518768 A JP2013518768 A JP 2013518768A JP 2013518768 A JP2013518768 A JP 2013518768A JP 2013531801 A5 JP2013531801 A5 JP 2013531801A5
- Authority
- JP
- Japan
- Prior art keywords
- hapten
- peroxidase
- sample
- conjugate
- subsequent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000003992 Peroxidases Human genes 0.000 claims 13
- 108040007629 peroxidase activity proteins Proteins 0.000 claims 13
- DZGWFCGJZKJUFP-UHFFFAOYSA-N tyramine Chemical compound NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 claims 9
- 125000003118 aryl group Chemical group 0.000 claims 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 4
- 229940127121 immunoconjugate Drugs 0.000 claims 4
- 150000002978 peroxides Chemical class 0.000 claims 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims 4
- 230000003100 immobilizing effect Effects 0.000 claims 3
- 229960003732 tyramine Drugs 0.000 claims 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 125000001931 aliphatic group Chemical group 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- -1 dinitrophenyl Chemical group 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 239000011593 sulfur Substances 0.000 claims 2
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 claims 1
- AWBOSXFRPFZLOP-UHFFFAOYSA-N 2,1,3-benzoxadiazole Chemical compound C1=CC=CC2=NON=C21 AWBOSXFRPFZLOP-UHFFFAOYSA-N 0.000 claims 1
- 125000001894 2,4,6-trinitrophenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O 0.000 claims 1
- WHCPTFFIERCDSB-UHFFFAOYSA-N 7-(diethylamino)-2-oxochromene-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)OC2=CC(N(CC)CC)=CC=C21 WHCPTFFIERCDSB-UHFFFAOYSA-N 0.000 claims 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 229940049706 benzodiazepine Drugs 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 claims 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 claims 1
- 239000007850 fluorescent dye Substances 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 150000005363 heterobiaryls Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000000415 inactivating effect Effects 0.000 claims 1
- 125000004999 nitroaryl group Chemical group 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 239000002096 quantum dot Substances 0.000 claims 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 claims 1
- JUVIOZPCNVVQFO-HBGVWJBISA-N rotenone Chemical compound O([C@H](CC1=C2O3)C(C)=C)C1=CC=C2C(=O)[C@@H]1[C@H]3COC2=C1C=C(OC)C(OC)=C2 JUVIOZPCNVVQFO-HBGVWJBISA-N 0.000 claims 1
- 125000004962 sulfoxyl group Chemical group 0.000 claims 1
- 150000003648 triterpenes Chemical class 0.000 claims 1
- 0 CC(C1)C(CCNC(C(C)(C)CCOC(C)(C)CNC(C#*)=*)=S)=C*=C1O Chemical compound CC(C1)C(CCNC(C(C)(C)CCOC(C)(C)CNC(C#*)=*)=S)=C*=C1O 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39894610P | 2010-07-02 | 2010-07-02 | |
| US61/398,946 | 2010-07-02 | ||
| US201161464216P | 2011-02-28 | 2011-02-28 | |
| US61/464,216 | 2011-02-28 | ||
| PCT/US2011/042849 WO2012003476A2 (en) | 2010-07-02 | 2011-07-01 | Hapten conjugates for target detection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013531801A JP2013531801A (ja) | 2013-08-08 |
| JP2013531801A5 true JP2013531801A5 (enExample) | 2014-07-17 |
Family
ID=44583735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013518768A Pending JP2013531801A (ja) | 2010-07-02 | 2011-07-01 | 標的検出のためのハプテンコンジュゲート |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20130109019A1 (enExample) |
| EP (1) | EP2588443A2 (enExample) |
| JP (1) | JP2013531801A (enExample) |
| AU (1) | AU2011274369A1 (enExample) |
| CA (1) | CA2800936A1 (enExample) |
| WO (1) | WO2012003476A2 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10267769B2 (en) | 2010-03-04 | 2019-04-23 | Ventana Medical Systems, Inc. | Processing system for processing specimens using acoustic energy |
| US10539487B2 (en) | 2010-03-04 | 2020-01-21 | Ventana Medical Systems, Inc. | Systems and methods for monitoring tissue sample processing |
| US10126216B2 (en) | 2011-02-17 | 2018-11-13 | Ventana Medical Systems, Inc. | Method for tissue sample fixation |
| WO2012003478A2 (en) | 2010-07-02 | 2012-01-05 | Ventana Medical Systems, Inc. | Detecting targets using mass tags and mass spectrometry |
| WO2013148498A1 (en) | 2012-03-27 | 2013-10-03 | Ventana Medical Systems, Inc. | Signaling conjugates and methods of use |
| WO2013167387A1 (en) | 2012-05-10 | 2013-11-14 | Ventana Medical Systems, Inc. | Uniquely specific probes for pten, pik3ca, met, top2a, and mdm2 |
| WO2014048942A1 (en) | 2012-09-25 | 2014-04-03 | Ventana Medical Systems, Inc. | Probes for pten, pik3ca, met, and top2a, and method for using the probes |
| JP6576835B2 (ja) * | 2013-03-12 | 2019-09-18 | ヴェンタナ メディカル システムズ， インク． | 標的物をｉｎｓｉｔｕ検出するための近接アッセイ |
| ES2804300T3 (es) | 2013-03-12 | 2021-02-05 | Ventana Med Syst Inc | Microscopía mejorada digitalmente para histología multiplexada |
| AU2014230469B2 (en) * | 2013-03-15 | 2017-07-13 | Ventana Medical Systems, Inc. | Spectral unmixing |
| WO2014151006A2 (en) | 2013-03-15 | 2014-09-25 | Genentech, Inc. | Biomarkers and methods of treating pd-1 and pd-l1 related conditions |
| CN110669826B (zh) | 2013-04-30 | 2025-01-07 | 加州理工学院 | 通过顺序杂交编条形码的分子多重标记 |
| ES2729638T3 (es) * | 2013-10-11 | 2019-11-05 | Ventana Med Syst Inc | Ensayos múltiplex de tinción conjunta de receptores de HER2 y de estrógenos para detectar heterogeneidad tumoral |
| EP3617322A1 (en) | 2014-02-24 | 2020-03-04 | Ventana Medical Systems, Inc. | Automated rna detection using labeled 2 -o-methyl rna oligonucleotide probes and signal amplification systems |
| DK3149042T3 (da) | 2014-05-29 | 2019-11-04 | Spring Bioscience Corp | PD-L1-antistoffer og anvendelser deraf |
| BR112017000497B1 (pt) | 2014-07-11 | 2023-12-26 | Ventana Medical Systems, Inc | Anticorpo isolado, célula hospedeira procariótica, imunoconjugado e método de detecção da presença ou do nível de expressão de pd-l1 |
| WO2016124558A1 (en) | 2015-02-03 | 2016-08-11 | Ventana Medical Systems, Inc. | Histochemical assay for evaluating expression of programmed death ligand 1 (pd-l1) |
| EP3270160B1 (en) * | 2015-03-13 | 2020-03-18 | Sysmex Corporation | Method for detecting test substance and reagent kit used in said method |
| RU2743169C2 (ru) | 2015-11-06 | 2021-02-15 | Вентана Медикал Системз, Инк. | Репрезентативная диагностика |
| ES2886600T3 (es) | 2015-11-22 | 2021-12-20 | Ventana Med Syst Inc | Procedimientos de identificación de células inmunitarias en tejido tumoral positivo para PD-L1 |
| JP6876062B2 (ja) | 2016-01-26 | 2021-05-26 | ヴェンタナ メディカル システムズ， インク． | 自動ダイセクション、次世代シークエンシング、及び自動スライド染色装置を用いる、腫瘍のための予測診断ワークフロー |
| AU2017229370B2 (en) | 2016-03-08 | 2021-03-11 | Ventana Medical Systems, Inc. | Multiplexed immunohistochemistry using recombinant antibodies with epitope tags |
| JP6736921B2 (ja) * | 2016-03-10 | 2020-08-05 | コニカミノルタ株式会社 | Ｆｉｓｈ染色方法 |
| WO2017175523A1 (ja) * | 2016-04-06 | 2017-10-12 | コニカミノルタ株式会社 | 蛍光免疫染色法 |
| EP3475701B1 (en) | 2016-06-28 | 2023-02-22 | Ventana Medical Systems, Inc. | New colors for chromogenic ihc and ish staining with multi-dye quinone methide and tyramide conjugates |
| WO2018055014A1 (en) | 2016-09-23 | 2018-03-29 | Ventana Medical Systems, Inc. | Methods and systems for scoring extracellular matrix biomarkers in tumor samples |
| WO2018118786A1 (en) | 2016-12-19 | 2018-06-28 | Ventana Medical Systems, Inc. | Methods and systems for quantitative immunohistochemistry |
| EP3659110A1 (en) | 2017-07-24 | 2020-06-03 | Ventana Medical Systems, Inc. | Methods and systems for evaluation of immune cell infiltrate in tumor samples |
| EP3710820B1 (en) | 2017-11-13 | 2025-06-11 | F. Hoffmann-La Roche AG | Devices for sample analysis using epitachophoresis |
| ES2965647T3 (es) | 2018-01-31 | 2024-04-16 | Ventana Med Syst Inc | Procedimientos y sistemas para la evaluación de infiltrado de células inmunitarias en cáncer colorrectal en estadio III |
| WO2019224153A1 (en) | 2018-05-21 | 2019-11-28 | Genentech, Inc. | Her2 heterogeneity as a biomarker in cancer |
| CN108918896A (zh) * | 2018-05-29 | 2018-11-30 | 郑州左安检测科技有限公司 | 一种检测苯二氮卓的fitc试纸条及其制备方法和应用方法 |
| CN108957017A (zh) * | 2018-05-29 | 2018-12-07 | 郑州左安检测科技有限公司 | 一种检测苯二氮卓的试纸条及其制备方法和应用方法 |
| EP3824288A1 (en) | 2018-07-17 | 2021-05-26 | Ventana Medical Systems, Inc. | Materials and methods for detecting fusion proteins |
| CN112673258B (zh) | 2018-09-13 | 2025-07-25 | 文塔纳医疗系统公司 | 用于检测ntrk融合蛋白的组织化学和细胞化学方法 |
| JP7455816B2 (ja) * | 2018-09-20 | 2024-03-26 | ヴェンタナ メディカル システムズ， インク． | クマリン系架橋試薬 |
| CN112789684B (zh) | 2018-10-01 | 2025-05-09 | 文塔纳医疗系统公司 | 用于预测对pd-1轴导向疗法的应答的方法和系统 |
| WO2020074742A1 (en) | 2018-10-12 | 2020-04-16 | F. Hoffmann-La Roche Ag | Detection methods for epitachophoresis workflow automation |
| JP7548903B2 (ja) | 2018-11-20 | 2024-09-10 | ヴェンタナ メディカル システムズ， インク． | 形態学的特徴およびバイオマーカー発現のために細胞サンプルを調製および分析するための方法およびシステム |
| JP7411667B2 (ja) | 2019-02-05 | 2024-01-11 | ヴェンタナ メディカル システムズ， インク． | ステージｉｖの結腸直腸がんにおける免疫細胞浸潤の評価のための方法及びシステム |
| WO2020229437A1 (en) | 2019-05-14 | 2020-11-19 | F. Hoffmann-La Roche Ag | Devices and methods for sample analysis |
| WO2021041874A1 (en) | 2019-08-29 | 2021-03-04 | Martin David C | Biofunctional thiophene monomers |
| CN115552248A (zh) | 2020-05-07 | 2022-12-30 | 文塔纳医疗系统公司 | 用于评价肿瘤样品中egfr和egfr配体表达的组织化学系统和方法 |
| EP4204398A2 (en) * | 2020-08-28 | 2023-07-05 | Ventana Medical Systems, Inc. | Conjugates including a detectable moiety |
| WO2022063787A1 (en) | 2020-09-22 | 2022-03-31 | Roche Diagnostics Gmbh | Antibodies specific for alpha-1,6-core-fucosylated psa and fucosylated fragments thereof |
| CN113552362B (zh) * | 2021-07-23 | 2024-08-09 | 湖北百奥斯生物科技有限公司 | 一种新型信号放大的免疫荧光试剂盒 |
| WO2023058624A1 (ja) * | 2021-10-08 | 2023-04-13 | コニカミノルタ株式会社 | 染色方法、評価方法および標本 |
| CN116444424B (zh) * | 2023-06-16 | 2023-09-08 | 广东省大湾区华南理工大学聚集诱导发光高等研究院 | 一种基于聚集诱导发光的酪酰胺荧光材料、免疫组化染色试剂盒及其应用 |
| CN121844210A (zh) | 2023-07-07 | 2026-04-10 | 文塔纳医疗系统公司 | 用于评估细胞中er、pr和ki-67生物标志物的共定位的明场三重免疫组织化学测定 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2320387A1 (de) * | 1973-04-21 | 1974-10-31 | Boehringer Mannheim Gmbh | Phenoxyalkylcarbonsaeurederivate und verfahren zur herstellung derselben |
| US4469797A (en) | 1982-09-23 | 1984-09-04 | Miles Laboratories, Inc. | Digoxigenin immunogens, antibodies, labeled conjugates, and related derivatives |
| EP0292202B1 (en) * | 1987-05-19 | 1992-09-02 | FISONS plc | 2-(3,4-dihydroxyphenyl ethyl amines, their preparation and use as pharmaceutical compounds |
| DE3836656A1 (de) | 1988-10-27 | 1990-05-03 | Boehringer Mannheim Gmbh | Neue digoxigenin-derivate und ihre verwendung |
| US5455143A (en) * | 1991-10-25 | 1995-10-03 | Minnesota Mining And Manufacturing Company | Aminoketone sensitizers for aqueous soluble photopolymer compositions |
| PT1621554E (pt) | 1992-08-21 | 2009-07-13 | Univ Bruxelles | Imunoglobtainas desprovidas de cadeias leves |
| US6005079A (en) | 1992-08-21 | 1999-12-21 | Vrije Universiteit Brussels | Immunoglobulins devoid of light chains |
| EP0933355A1 (en) * | 1997-12-24 | 1999-08-04 | Universiteit Maastricht | Preparation of tyramide conjugates |
| US6437146B1 (en) * | 1998-09-25 | 2002-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compounds as prostaglandin e2 agonists or antagonists |
| US6372937B1 (en) | 1998-11-09 | 2002-04-16 | Mark Norman Bobrow | Enhanced catalyzed reporter deposition |
| US6387900B1 (en) * | 1999-08-12 | 2002-05-14 | Pharmacia & Upjohn S.P.A. | 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents |
| ATE311378T1 (de) * | 1999-09-17 | 2005-12-15 | Nissan Chemical Ind Ltd | Benzopyran derivate |
| US6630469B2 (en) * | 2000-05-09 | 2003-10-07 | Bristol-Myers Squibb Company | 5-HT7 receptor antagonists |
| DE60112742T2 (de) * | 2000-05-19 | 2006-02-02 | Applied Research Systems Ars Holding N.V. | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit |
| US6649138B2 (en) | 2000-10-13 | 2003-11-18 | Quantum Dot Corporation | Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media |
| US20020083888A1 (en) | 2000-12-28 | 2002-07-04 | Zehnder Donald A. | Flow synthesis of quantum dot nanocrystals |
| WO2003092043A2 (en) | 2001-07-20 | 2003-11-06 | Quantum Dot Corporation | Luminescent nanoparticles and methods for their preparation |
| WO2003057669A1 (fr) * | 2001-12-28 | 2003-07-17 | Takeda Chemical Industries, Ltd. | Antagonistes du recepteur androgene |
| EP1627420B1 (en) | 2003-05-07 | 2020-07-15 | Indiana University Research and Technology Corporation | Alloyed semiconductor quantum dots and concentration-gradient alloyed quantum dots, series comprising the same and methods related thereto |
| WO2005007621A2 (en) * | 2003-05-30 | 2005-01-27 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
| JP4411153B2 (ja) * | 2003-07-18 | 2010-02-10 | 富士フイルム株式会社 | ２光子吸収色素消色材料、３次元的屈折率変調材料、３次元吸収率変調材料及び３次元光記録材料 |
| KR100657891B1 (ko) | 2003-07-19 | 2006-12-14 | 삼성전자주식회사 | 반도체 나노결정 및 그 제조방법 |
| DE10348022A1 (de) * | 2003-10-15 | 2005-05-25 | Imtm Gmbh | Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
| GB0324551D0 (en) * | 2003-10-21 | 2003-11-26 | Karobio Ab | Novel compounds |
| US7323567B2 (en) * | 2003-10-30 | 2008-01-29 | Boehringer Ingelheim (Canada) Ltd. | RSV polymerase inhibitors |
| TW200533357A (en) * | 2004-01-08 | 2005-10-16 | Millennium Pharm Inc | 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
| US20060246423A1 (en) | 2005-02-10 | 2006-11-02 | Adelson Martin E | Method and kit for the collection and maintenance of the detectability of a plurality of microbiological species in a single gynecological sample |
| CA2606018A1 (en) | 2005-04-28 | 2006-11-02 | Ventana Medical Systems, Inc. | Nanoparticle conjugates |
| ES2548518T3 (es) | 2005-11-23 | 2015-10-19 | Ventana Medical Systems, Inc. | Conjugado molecular |
| US7695929B2 (en) * | 2006-11-01 | 2010-04-13 | Ventana Medical Systems, Inc. | Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
| JP2008228637A (ja) * | 2007-03-20 | 2008-10-02 | Tokushima Bunri Univ | 蛍光相関分光測定法を用いた過酸化水素量の測定方法及びその利用方法 |
| US20080299555A1 (en) * | 2007-05-30 | 2008-12-04 | Hiroaki Nitta | Multicolor chromogenic detection of biomarkers |
| WO2010121963A1 (en) * | 2009-04-21 | 2010-10-28 | Nerviano Medical Sciences S.R.L. | Resorcinol derivatives as hsp90 inhibitors |
| WO2012003478A2 (en) * | 2010-07-02 | 2012-01-05 | Ventana Medical Systems, Inc. | Detecting targets using mass tags and mass spectrometry |
-
2011
- 2011-07-01 JP JP2013518768A patent/JP2013531801A/ja active Pending
- 2011-07-01 US US13/805,978 patent/US20130109019A1/en not_active Abandoned
- 2011-07-01 EP EP11738526.0A patent/EP2588443A2/en not_active Withdrawn
- 2011-07-01 CA CA2800936A patent/CA2800936A1/en not_active Abandoned
- 2011-07-01 WO PCT/US2011/042849 patent/WO2012003476A2/en not_active Ceased
- 2011-07-01 AU AU2011274369A patent/AU2011274369A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009070640A3 (en) | Methods and compositions for amplifying a detectable signal | |
| CA2753596A1 (en) | Non separation assays with selective signal inhibitors | |
| WO2012003476A3 (en) | Hapten conjugates for target detection | |
| JP2010539456A5 (enExample) | ||
| NO20080249L (no) | Transglutaminaseformidlet konjugasjon av veksthormon | |
| JP2015529208A5 (enExample) | ||
| JP2019519490A5 (enExample) | ||
| EP2444807A3 (en) | Haptens, hapten conjugates, compositions thereof and method for their preparation and use | |
| WO2004042030A3 (en) | Displacement sandwich immuno-pcr | |
| WO2007109129A8 (en) | Methods for preparing complex multivalent immunogenic conjugates | |
| JP2015529197A5 (enExample) | ||
| WO2022223783A8 (en) | Thiol-conjugation with unsaturated phosphorus(v) compounds | |
| WO2009135598A8 (en) | Process for preparing substituted biphenylanilides | |
| JP2020500186A5 (enExample) | ||
| Ábrányi-Balogh et al. | Warheads for designing covalent inhibitors and chemical probes | |
| UA94594C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ ПОЛИМЕРНЫХ КОНЪЮГАТОВ ДОКСОРУБИЦИНА С рН-КОНТРОЛИРОВАННЫМ ВЫСВОБОЖДЕНИЕМ ЛЕКАРСТВЕННОГО ВЕЩЕСТВА | |
| TWI464402B (zh) | 將核酸接上小分子的方法 | |
| Lee et al. | Cyclic acetals as cleavable linkers for affinity capture | |
| WO2006102722A8 (en) | Process for the production of ϝ-glutamylcysteine | |
| AR051341A1 (es) | Proceso para la preparacion de derivados de [1,4,5]-oxadiazepina | |
| EP2237035A3 (en) | Taxol derivatives for taxol immunoassay | |
| RU2010123168A (ru) | Комплекс нуклеиновой кислоты и композиция для доставки нуклеиновой кислоты | |
| CA2641542A1 (en) | Improved process for producing nitroisourea derivatives | |
| WO2012081856A3 (en) | Method for preparing nucleic acid probe-coated porous solid support strip | |
| Pryde et al. | Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder |